Searched for
GERMANY PHARMA COMPANY
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inf...- Why did stock market rally today? Sensex jumps 736 points, Nifty closes above 23,850. 5 key factors behind bull runIndian equities surged nearly 1% as bulls charged through Dalal Street, driven by an Iran-US peace framework and sliding oil prices. The Se...
- Market Wrap: Sensex falls 479 points, Nifty below 23,950 as bank stocks falter; small, midcaps shineIndian benchmark indices Sensex and Nifty closed significantly lower on Tuesday, impacted by a downturn in banking, oil and gas, and pharma...
- Why market rallied today? Sensex jumps 1,074 points, Nifty closes above 24,000. 5 factors behind surgeIndian stock markets surged on Monday, with Sensex and Nifty rallying over 1% each, driven by rising hopes of a US-Iran peace deal and fall...
- Sakar Healthcare partners with Zydus Lifesciences for GCC MarketsSakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks ...
- Ahead of Market: 10 things that will decide stock market action on ThursdayBenchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....
- Ahead of Market: 10 things that will decide stock market action on FridayBSE Sensex and Nifty 50 extended gains for a second session, led by banking, metal and pharma stocks despite IT weakness. Analysts flagged ...
- Why market rose today? Sensex rises 790 points, Nifty closes near 23,700. 5 key drivers behind surgeIndian stock markets are experiencing a significant rally. The BSE Sensex and Nifty 50 indices have climbed over 1 percent each. This surge...
- Sensex surges over 800 points to cross 75,400; Nifty above 23,650 despite weak rupeeIn a recent turn of fortunes, Indian stock markets experienced a notable rise for the second consecutive day. On Thursday, both the Sensex ...
- Bulls back on D-St! Sensex rallies over 940 pts, Nifty closes above 24,330. Here's whyIndian stock markets surged over 1% on Wednesday, with the Sensex and Nifty reversing early losses. This rebound was triggered by a report ...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- Why market fell today? Sensex slumps 583 pts, Nifty below 24,000; 7 key triggersIndian stock markets experienced a significant downturn on Thursday, with Sensex and Nifty both falling over 0.7%. This decline was driven ...
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty 50 and BSE Sensex declined amid selling in banking, auto and IT stocks. Markets remain range-bound, awaiting triggers, with analysts ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- Sensex jumps 639 pts, Nifty ends above 24,050 to snap 3-day losing run. What drove the rally?Indian markets surged on Monday, ending a losing streak. Investor sentiment improved following reports of Iran sending a peace proposal to ...
- Stock Market Crash Today: D-Street investors lose Rs 5 lakh crore. 7 reasons why Sensex and Nifty fellIndian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...
- Why stock market fell today? Sensex plunges 850 pts, Nifty below 24,200. 6 reasons behind selloffIndian equity benchmarks declined for a second straight session, pressured by a spike in crude oil prices, a weakening rupee and rising geo...
- Venus Pharma ties up with Mylan for marketing of antibiotic MeropenemThe deal with Mylan will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for a period of five years.
- Pharma companies should have clear rules for business in India: GermanyBahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...
- German pharma company Boehringer Ingelheim remains bullish on R&D and India"I am quite convinced that as more and more Indian generic companies start doing their own research, I think it will change the conditions ...
Load More
